2019
DOI: 10.1523/jneurosci.2472-18.2019
|View full text |Cite
|
Sign up to set email alerts
|

Noradrenergic α1-Adrenoceptor Actions in the Primate Dorsolateral Prefrontal Cortex

Abstract: Noradrenergic (NE) ␣1-adrenoceptors (␣1-ARs) contribute to arousal mechanisms and play an important role in therapeutic medications such as those for the treatment of posttraumatic stress disorder (PTSD). However, little is known about how ␣1-AR stimulation influences neuronal firing in the dorsolateral prefrontal cortex (dlPFC), a newly evolved region that is dysfunctional in PTSD and other mental illnesses. The current study examined the effects of ␣1-AR manipulation on neuronal firing in dlPFC of rhesus mon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
20
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 67 publications
(88 reference statements)
2
20
0
Order By: Relevance
“…Whereas these studies did not report in vivo effects on astrocytic and neuronal activity, we showed rapid reduction of neuronal activity and depression of evoked response after astrocytic Gq activation ( Fig. 3 ), in line with the recent monkey prefrontal cortex study with α1AR agonists 53 . Aside from the preparation differences, one important aspect of the current study is the use of transgenic mice that minimizes concerns on tissue inflammation caused by virus-injection and slice preparation.…”
Section: Discussionsupporting
confidence: 92%
“…Whereas these studies did not report in vivo effects on astrocytic and neuronal activity, we showed rapid reduction of neuronal activity and depression of evoked response after astrocytic Gq activation ( Fig. 3 ), in line with the recent monkey prefrontal cortex study with α1AR agonists 53 . Aside from the preparation differences, one important aspect of the current study is the use of transgenic mice that minimizes concerns on tissue inflammation caused by virus-injection and slice preparation.…”
Section: Discussionsupporting
confidence: 92%
“…High levels of dopamine (DA) D1R and norepinephrine (NE) α1-AR stimulation in the PFC impair working memory performance by driving feedforward calcium-cAMP-K + signaling [66,67,68,69], as schematically illustrated in Figure 3. Both α1R (Figure 3A; [70]) and D1R [57,71] have been localized on dendritic spines in layer III of primate dlPFC, and their activation drives feedforward calcium-cAMP signaling (Figure 3B). Thus, stimulation of α1R or D1R reduces the task-related firing of dlPFC neurons in monkeys performing a working memory task, while blockade or closure of HCN channels rescues firing [68,69,70,72].…”
Section: Stress Rapidly Takes Pfc Circuits “Offline”mentioning
confidence: 99%
“…Both α1R (Figure 3A; [70]) and D1R [57,71] have been localized on dendritic spines in layer III of primate dlPFC, and their activation drives feedforward calcium-cAMP signaling (Figure 3B). Thus, stimulation of α1R or D1R reduces the task-related firing of dlPFC neurons in monkeys performing a working memory task, while blockade or closure of HCN channels rescues firing [68,69,70,72]. These stress signaling pathways may interact with neuroinflammation, which may remove the brakes on the stress response by inhibiting PDE4s, as illustrated in Figure 3B.…”
Section: Stress Rapidly Takes Pfc Circuits “Offline”mentioning
confidence: 99%
See 1 more Smart Citation
“…Over the past decade, α 1 -adrenoceptor has gained interest due to its biological functions in regulating both positively motivated behaviors and stress reactions (Selken and Nichols, 2007;Stone et al, 2007). The α 1adrenoceptor has been implicated in numerous neuronal diseases, such as Alzheimer's disease, Parkinson's disease, schizophrenia, substance abuse, and affective disorders (Maletic et al, 2017;Wu et al, 2017;Akinaga et al, 2019;Datta et al, 2019). Consequently, a great deal of interests lay in the development of α 1 -adrenoceptor modulators, which has opened a new avenue for identifying novel CNS disease modifying therapeutics.…”
Section: Introductionmentioning
confidence: 99%